Global device conference draft programme released
This article was originally published in Clinica
The US FDA's director of international policy, Linda Horton, is scheduled to give "the regulators' response" to the progress made to date on mutual recognition and global harmony at the 7th Global Medical Device Conference in Sydney, Australia, on February 15-18th, 1998. Also representing the regulatory point of view will be Terry Slater of Australia's Therapeutic Goods Administration, the draft programme for the conference shows.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.